Inhaled corticosteroid therapy helps reduce pneumonia mortalityApril 16th, 2011 - 2:18 pm ICT by ANI
Washington, April 16 (ANI): An analysis has indicated that patients with chronic obstructive pulmonary disease (COPD) who are hospitalized for pneumonia and treated with inhaled corticosteroids (ICS) have decreased mortality when compared to those who are not treated with ICS.
The use of ICS in COPD patients reduces exacerbations, but increases the rate of pneumonia.
Mortensen and colleagues examined the medical records of 15,768 COPD patients over the age of 65 who had been admitted to the VA hospitals. The study found that those who were not treated with ICS had about a 25 percent greater mortality risk than those who were treated with ICS.
“These results have clear implications for current clinical practice, which has been informed in the past by a series of studies that found an increased risk of pneumonia with ICS use,” said Eric Mortensen, investigator at VERDICT (Veterans Evidence-based Research, Dissemination, and Implementation Center, a VA Health Services Research and Development program) and principal investigator on the study.
“In contrast, our study would suggest that ICS use may confer a survival benefit to these patients and may be employed when there are not contraindications. These results should reassure clinicians that they can give their COPD patients ICS without fearing that the increased risk of pneumonia will translate into higher risk of mortality,” added Mortensen.
The results have been published in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. (ANI)
- Inhaled steroids up diabetes risk: Study - Nov 02, 2010
- Inhaled corticosteroids may increase diabetes risk - Dec 15, 2010
- Long-term air pollution exposure 'ups risk of severe COPD' - Oct 20, 2010
- Now, alternate therapy for adults with poorly controlled asthma - Sep 20, 2010
- Long-term use of popular inhalers ups pneumonia risk for COPD patients - Feb 10, 2009
- Pulmonary rehabilitation benefits both obese and slim COPD patients - May 17, 2010
- Beta-blockers 'linked to benefits in patients with lung disease' - May 25, 2010
- Four novel biomarkers that may help diagnose asthma, COPD identified - Mar 12, 2011
- Early antibiotic treatment for chronic disorder shows improvement - May 26, 2010
- Controlled oxygen therapy slashes death rate among COPD patients - Oct 22, 2010
- Simple blood test could provide early detection of emphysema - Mar 12, 2011
- Elderly more prone to community-acquired pneumonia - May 27, 2011
- Poor people are most hard-hit by TB, COPD and tobacco - Nov 06, 2010
- Prevent gum disease to keep lungs healthy - Jan 19, 2011
- Regular use of vitamin E may cut COPD risk - May 17, 2010
Tags: american journal of respiratory and critical care, american journal of respiratory and critical care medic, american thoracic society, chronic obstructive pulmonary disease, copd patients, corticosteroid therapy, critical care medicine, evidence based research, exacerbations, health services research, implementation center, inhaled corticosteroids, medical records, mortality risk, obstructive pulmonary disease, pneumonia, principal investigator, research dissemination, respiratory and critical care medicine, survival benefit